CCRB Logo

Trial Detail

CUHK_CCT00371

2013-06-14

Prospective

CRE-2012.514-T

NA

Division of Neurology, Department of Medicine & Therapeutics, The Chinese University of Hong Kong

NA

Not Applicable

Roxanna LIU

Division of Neurology, Dept of Medicine and Therapeutics,PWH

3505 3877

roxannaliu@cuhk.edu.hk

Division of Neurology, Dept of Medicine and Therapeutics,PWH,CUHK

Hong Kong

Ka Sing WONG

Division of Neurology, Dept of Medicine and Therapeutics,PWH

3505 3877

ks-wong@cuhk.edu.hk

Dept of Medicine and Therapeutics, PWH,CUHK

Hong Kong

A randomized controlled trial of transcranial magnetic stimulationand robotic-hand therapy to improve hand function after ischemic stroke

A randomized controlled trial of transcranial magnetic stimulationand robotic-hand therapy to improve hand function after ischemic stroke

機械手及經顱磁刺激聯合療法對中風病人手部運動功能康復的研究

TBS-ROBOT

HK, CHINA

Yes

2013-01-22

Joint CUHK-NTEC Clinical Research Ethics Committee

2012.514-T

stroke

Device

transcranial magnetic stimulation &
robotic-hand therapy

NA

NA

3 min for TBS, 45 min for hand therapy

10 sessions for TBS ,20 sessions for robotic-hand therapy

sham transcranial magnetic stimulation

NA

NA

3 min for TBS, 45 min for hand therapy

10 sessions for TBS ,20 sessions for robotic-hand therapy

1) patients aged 18 or above; 2) first-ever ischemic subcortical stroke with onset time less than 21 days; 3) hand weakness as a result of stroke; 4) intracerebral hemorrhage excluded by brain computed tomography (CT) / magnetic resonance imaging (MRI) ; 5) the patient or his/her legally acceptable representative is willing to provide written informed consent.

1) personal history of epilepsy; 2) metallic implants in any part of body; 3) implanted cardiac pacemaker, defibrillator, medication pump or any other implanted electronics; 4) severe skull fracture, serious head injury, history of brain or spinal cord surgery; 5) brain tumour or other significant non-ischemic brain lesion on CT/MRI; 6) administration of drugs that potentially lower seizure threshold; 7) severe hand spasticity, open hand wound or hand deformity; 8) history of malignancy; 9) severe co-existing systemic diseases, severe dementia or psychosis; 10) inability to be followed up at regular interval; 11) pregnancy or breast-feeding

18

90

Both Male and Female

Interventional

Randomized

double blinded

Placebo

Not Applicable

Parallel

0

2013-07-01

63

Suspended

Upper limb fugl-meyer assessment (FMA)at week 12 after stroke

RMT, AMT, MEP, S/R curve, Power Grip, Lateral Pinch Grip, Purdue Pegboard for both hands ,NIHSS,mRS at baseline,week 4, week 8, week 12, week 24 after stroke.

No

2017-04-25

ChiCTR-TRC-13003417

Type Document Published On  
No documents yet.
  • Page 1 of 1.